Indication

Exocrine pancreatic insufficiency

Exocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate. Read more about Exocrine pancreatic insufficiency

28 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Exocrine pancreatic insufficiency therapies.

Showing 19–27 of 28 drugs

Filter & compare in the drug finder →Opens the drug finder with Exocrine pancreatic insufficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Exocrine pancreatic insufficiency.

Exocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate.

This deficit disrupts normal gastrointestinal nutrient breakdown, resulting in global maldigestion and secondary malabsorption.

Pathophysiologically driven by parenchymal destruction, ductal obstruction, or postcibal asynchrony, it most frequently occurs in adults with chronic pancreatitis and in pediatric populations with cystic fibrosis, as well as following gastrointestinal surgeries or pancreatic neoplasms.

Clinically, affected individuals present with steatorrhea, abdominal pain, bloating, weight loss, and secondary complications related to fat-soluble vitamin deficiencies and chronic malnutrition.

Personalize your experience

Follow Exocrine pancreatic insufficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it